NASDAQ:NLSP

NLS Pharmaceutics AG Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology

$0.168

-0.0100 (-5.61%)

At Close: Jun 25, 2024

NLS Pharmaceutics AG Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 NLSP shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About NLS Pharmaceutics AG

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to ... NLSP Profile

Golden Star

Ticker	Date	Change	Price
EVBG	Jun 21	0.0863%	$34.76
DDOG	Jun 21	1.33%	$117.57
BRK-A	Jun 20	0.575%	$617,249.90
EPD	Jun 18	2.90%	$28.30
USFD	Jun 18	4.33%	$53.14
INTC	Jun 18	0.359%	$30.63
UFPT	Jun 18	2.05%	$253.79
^DJI	Jun 18	0.714%	38,834.86 points
RGA	Jun 17	1.53%	$203.90
MA	Jun 17	1.68%	$448.11

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In